Björkman O, Felig P
Diabetes. 1982 Jun;31(6 Pt 1):516-20. doi: 10.2337/diab.31.6.516.
Arterial (A) and renal venous (RV) concentrations and net splanchnic exchange of glucose, fructose, lactate, pyruvate, glycerol, and alanine were studied in the basal state and during a 135-min intravenous infusion of fructose at 2 mmol/min in healthy subjects after a 60-h fast. After 45 min of the fructose infusion, somatostatin (9 microgram/min) was infused for 60 min to induce hypoglucagonemia. Fructose infusion resulted in a net uptake of this hexose by the kidney as well as the splanchnic bed. Estimated renal uptake of fructose could account for the disposal of 20% of the administered fructose load while splanchnic uptake accounted for 38%. The fructose infusion resulted in a rise in blood glucose of 0.9 mmol/L, a 35% increase in net glucose output from the splanchnic bed, and a consistent net output of glucose from the kidney (A-RV = -0.17 +/- 0.05 mmol/L as compared with 0 +/- 0.03 in the basal state, P less than 0.02). Net glucose release from the kidney could account for 55% of the net renal uptake of fructose. The fructose infusion also resulted in a marked change in renal lactate balance from a net uptake in the basal state (A - RV = 0.05 +/- 0.01 mmol/L) to a net output during fructose administration (A - RV = -0.10 +/- 0.04). Administration of somatostatin resulted in a fall in arterial glucagon levels and a 35% decrease in splanchnic glucose output but failed to alter the arterial-renal venous difference for glucose observed during the fructose infusion. We conclude that in 60-h fasted man: (a) intravenous infusion of fructose results in a net uptake of this hexose by the kidney as well as the liver, (b) this uptake is accompanied by stimulation of renal as well as hepatic glucose production and renal production of lactate, and (c) hypoglucagonemia inhibits splanchnic but not renal glucose output during fructose infusion. These data indicate that the kidney is an important site of fructose disposal and that glucose and lactate are end products of renal fructose metabolism.
在健康受试者禁食60小时后,研究了基础状态下以及以2 mmol/min的速率静脉输注果糖135分钟期间,动脉(A)和肾静脉(RV)中葡萄糖、果糖、乳酸、丙酮酸、甘油和丙氨酸的浓度以及内脏的净交换情况。在果糖输注45分钟后,输注生长抑素(9微克/分钟)60分钟以诱导低胰高血糖素血症。果糖输注导致肾脏以及内脏床对这种己糖的净摄取。估计肾脏对果糖的摄取可占所给予果糖负荷的20%,而内脏摄取占38%。果糖输注导致血糖升高0.9 mmol/L,内脏床葡萄糖净输出增加35%,并且肾脏持续有葡萄糖净输出(A - RV = -0.17 ± 0.05 mmol/L,而基础状态下为0 ± 0.03 mmol/L,P < 0.02)。肾脏的葡萄糖净释放可占肾脏对果糖净摄取的55%。果糖输注还导致肾脏乳酸平衡发生显著变化,从基础状态下的净摄取(A - RV = 0.05 ± 0.01 mmol/L)变为果糖输注期间的净输出(A - RV = -0.10 ± 0.04)。生长抑素的给药导致动脉胰高血糖素水平下降以及内脏葡萄糖输出减少35%,但未能改变果糖输注期间观察到的葡萄糖的动静脉差异。我们得出结论,在禁食60小时的人体中:(a)静脉输注果糖导致肾脏以及肝脏对这种己糖的净摄取;(b)这种摄取伴随着肾脏以及肝脏葡萄糖生成的刺激以及肾脏乳酸生成;(c)低胰高血糖素血症在果糖输注期间抑制内脏而非肾脏的葡萄糖输出。这些数据表明,肾脏是果糖代谢的重要场所,并且葡萄糖和乳酸是肾脏果糖代谢的终产物。